10-K: FY2024 Annual Report
8-K: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
8-K: Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results
10-Q: Q3 2024 Earnings Report
Applied DNA Sciences Second Quarter 2024 Earnings: Misses Expectations
10-Q: Q2 2024 Earnings Report
No Data